Therapeutic Proteins International, LLC

4DTEST

FOUR D TEST; FOR D TEST;Biopharmaceutical assay for determining the fourth dimensional structure of a macromolecule solution for scientific and research use;

EVERY PATIENT SERVED

providing financial payment assistance to patients for pharmaceuticals;Administration of patient reimbursement programs; administration of prescription drug co-payment programs;PATIENT;

JUST AHEAD OF TIME

Scientific instruments and apparatus, namely, laboratory instruments for performing biotechnological manufacturing of biologic proteins for scaling up or down quickly in response to the needs of the pharmaceutical biologics market; disposable articles for use with laboratory instruments, namely, disposable bioreactors, laboratory apparatuses for protein purification; computer software and hardware for use in life sciences and pharmaceutical industries for storage, analysis and evaluation of collected data;Printed materials, namely, newsletters, pamphlets, magazines, reports, books, manuals, leaflets, convention displays, journals, printed slide presentations, printed slide cards, bulletins, flashcards, posters, brochures, training materials, calendars, mounted posters, printed charts, printed paper signs and guides featuring information on prescription drugs, prescription drug research, prescription drug use, prescription drug manufacturing, treatment and therapies;

MAKING LIFESAVING DRUGS AFFORDABLE

providing financial payment assistance to patients for pharmaceuticals;Administration of patient reimbursement programs; administration of prescription drug co-payment programs;

NO PATIENT LEFT BEHIND

providing financial payment assistance to patients for pharmaceuticals;Administration of patient reimbursement programs; administration of prescription drug co-payment programs;

PEG-THERAGRASIM

pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production;

SYMADALI

pharmaceutical preparations for treatment of autoimmune diseases;

SYMBEVAC

pharmaceutical preparations for the treatment of proliferative disorders, namely, angiogenic disorders, cancer;

SYMETAN

pharmaceutical preparations for treating human immune diseases and conditions;

SYMGRASTA

pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production;

SYMNEUVA

prescription pharmaceutical preparations for use in stimulating white blood cell production;

SYMREM

pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders;

SYMRITUX

pharmaceutical preparations for the treatment of cancer and medical diagnostic reagents;

SYMTRAST

pharmaceutical preparations for the treatment of cancer;

SYNC OR SINK

Tool for coordinating workflow around departments to improve efficiency and productivity;

THERADALINAB

pharmaceutical preparations for treatment of autoimmune diseases;

THERAGRASIM

prescription pharmaceutical for use in stimulating white blood cell production;

THERAPROTEINS

House mark for a full line of pharmaceuticals containing protein; pharmaceutical preparations containing protein, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; erythropoiesis stimulating protein; pharmaceuticals containing protein for stimulating white blood cell production; pharmaceuticals containing protein for treating human immune diseases and conditions; pharmaceutical preparations containing protein for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; pharmaceutical compositions containing protein for treatment of autoimmune diseases and disorders; pharmaceutical preparations containing protein for the treatment of proliferative disorders, namely, angiogenic disorders and cancer; and pre-filled syringes containing pharmaceutical preparations containing protein for treatment of the aforementioned diseases and disorders and complications associated therewith;THERA PROTEINS; THERAPEUTIC PROTEINS;

THERMODYNAMIC EQUIVALENCE SURROGATE TEST (TEST)

analysis of pharmaceutical preparations for thermodynamic equivalence to a reference product as a surrogate for clinical testing;

TPI

House mark for a full line of pharmaceuticals; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of oncological and inflammatory diseases and disorders, and complications associated therewith; erythropoiesis stimulating protein; pharmaceuticals for stimulating white blood cell production; pharmaceuticals for treating human immune diseases and conditions; pharmaceutical preparations for the treatment of multiple sclerosis, lymphoma, leukemia and transplant rejections; and pre-filled syringes containing pharmaceutical preparations for treatment of the aforementioned diseases and disorders and complications associated therewith;THERAPEUTIC PROTEINS INTERNATIONAL;TPI;

TPI ASSIST

providing financial payment assistance to patients for pharmaceuticals;THERAPEUTIC PROTEINS INTERNATIONAL ASSIST;Administration of patient reimbursement programs; administration of prescription drug co-payment programs;ASSIST;